Transcription of DRUG NAME: Erlotinib - BC Cancer
{{id}} {{{paragraph}}}
Example: dental hygienist
DRUG NAME: Erlotinib - BC Cancer
Erlotinib BC Cancer Agency Cancer drug Manual Page 1 of 5 Erlotinib Developed: December 2005 Limited revision: 1 April 2009, 1 June 2010, 1 April 2011, 1 July 2014 drug name : Erlotinib SYNONYM(S): OSI-774 COMMON TRADE name (S): TARCEVA CLASSIFICATION: epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor1 Special pediatric considerations are noted when applicable, otherwise adult provisions apply. MECHANISM OF ACTION: Erlotinib is an EGFR-specific tyrosine kinase It inhibits EGFR autophosphorylation and therefore EGF-dependent cell proliferation.
Erlotinib BC Cancer Agency Cancer Drug Manual© Page 1 of 5 Erlotinib Developed: December 2005 Limited revision: 1 April 2009, 1 June 2010, 1 April 2011, 1 July 2014 DRUG NAME: Erlotinib
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
MONOGRAPH TRIMEBUTINE, MONOGRAPH TRIMEBUTINE Trimebutine, Tablets, Revision, REVISION OF MONOGRAPH ON TABLETS, Monograph, PRODUCT MONOGRAPH, PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION, PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION, Disintegration test for tablets and, DRUG NAME: Dexamethasone